

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.81984295 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.75089878 |
| 3 | locomotory exploration behavior (GO:0035641) | 5.64305010 |
| 4 | synaptic vesicle maturation (GO:0016188) | 5.40441458 |
| 5 | vocalization behavior (GO:0071625) | 5.23204527 |
| 6 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.16087464 |
| 7 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.96236004 |
| 8 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.90547128 |
| 9 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.85272568 |
| 10 | synaptic vesicle exocytosis (GO:0016079) | 4.81421490 |
| 11 | regulation of synapse structural plasticity (GO:0051823) | 4.78234796 |
| 12 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.68032742 |
| 13 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.61161533 |
| 14 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.57889562 |
| 15 | protein localization to synapse (GO:0035418) | 4.53611523 |
| 16 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.46552756 |
| 17 | glutamate secretion (GO:0014047) | 4.41026113 |
| 18 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.40031311 |
| 19 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.37674952 |
| 20 | neuronal action potential propagation (GO:0019227) | 4.34352192 |
| 21 | presynaptic membrane organization (GO:0097090) | 4.29758894 |
| 22 | exploration behavior (GO:0035640) | 4.24281155 |
| 23 | synaptic transmission, glutamatergic (GO:0035249) | 4.21467186 |
| 24 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.19878132 |
| 25 | neuron-neuron synaptic transmission (GO:0007270) | 4.17527375 |
| 26 | neuron cell-cell adhesion (GO:0007158) | 4.15400146 |
| 27 | dendritic spine morphogenesis (GO:0060997) | 4.15244445 |
| 28 | glutamate receptor signaling pathway (GO:0007215) | 4.15066037 |
| 29 | regulation of synaptic vesicle transport (GO:1902803) | 4.12959274 |
| 30 | neurotransmitter secretion (GO:0007269) | 4.08497115 |
| 31 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.98778703 |
| 32 | long-term memory (GO:0007616) | 3.96364587 |
| 33 | prepulse inhibition (GO:0060134) | 3.93483426 |
| 34 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.93436751 |
| 35 | auditory behavior (GO:0031223) | 3.89795392 |
| 36 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.89326925 |
| 37 | positive regulation of membrane potential (GO:0045838) | 3.86105128 |
| 38 | layer formation in cerebral cortex (GO:0021819) | 3.85071570 |
| 39 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.84518735 |
| 40 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.82178471 |
| 41 | regulation of postsynaptic membrane potential (GO:0060078) | 3.78734859 |
| 42 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.74258755 |
| 43 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.66000339 |
| 44 | neuromuscular process controlling balance (GO:0050885) | 3.65843601 |
| 45 | regulation of synaptic plasticity (GO:0048167) | 3.62898735 |
| 46 | response to auditory stimulus (GO:0010996) | 3.62402710 |
| 47 | positive regulation of neurotransmitter transport (GO:0051590) | 3.60810858 |
| 48 | gamma-aminobutyric acid transport (GO:0015812) | 3.60774456 |
| 49 | striatum development (GO:0021756) | 3.59024985 |
| 50 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.58130987 |
| 51 | transmission of nerve impulse (GO:0019226) | 3.57638822 |
| 52 | long-term synaptic potentiation (GO:0060291) | 3.53393636 |
| 53 | nucleobase catabolic process (GO:0046113) | 3.53186475 |
| 54 | synaptic transmission, dopaminergic (GO:0001963) | 3.48636713 |
| 55 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.47034311 |
| 56 | response to histamine (GO:0034776) | 3.46420512 |
| 57 | cellular potassium ion homeostasis (GO:0030007) | 3.38747269 |
| 58 | behavioral defense response (GO:0002209) | 3.37432070 |
| 59 | behavioral fear response (GO:0001662) | 3.37432070 |
| 60 | behavioral response to cocaine (GO:0048148) | 3.34145710 |
| 61 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.34060314 |
| 62 | membrane hyperpolarization (GO:0060081) | 3.33889006 |
| 63 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.33305454 |
| 64 | activation of protein kinase A activity (GO:0034199) | 3.33224544 |
| 65 | neurotransmitter transport (GO:0006836) | 3.31538815 |
| 66 | startle response (GO:0001964) | 3.31360251 |
| 67 | neuron recognition (GO:0008038) | 3.28321491 |
| 68 | regulation of dendritic spine development (GO:0060998) | 3.27578063 |
| 69 | positive regulation of synapse maturation (GO:0090129) | 3.26012176 |
| 70 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.25124305 |
| 71 | neuronal ion channel clustering (GO:0045161) | 3.24985296 |
| 72 | regulation of neurotransmitter secretion (GO:0046928) | 3.24080674 |
| 73 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.23775585 |
| 74 | retinal ganglion cell axon guidance (GO:0031290) | 3.22858373 |
| 75 | membrane depolarization (GO:0051899) | 3.22735460 |
| 76 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.21163933 |
| 77 | postsynaptic membrane organization (GO:0001941) | 3.20711849 |
| 78 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.19131255 |
| 79 | mechanosensory behavior (GO:0007638) | 3.19073045 |
| 80 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.18539515 |
| 81 | nonmotile primary cilium assembly (GO:0035058) | 3.16695353 |
| 82 | membrane depolarization during action potential (GO:0086010) | 3.16419116 |
| 83 | regulation of neurotransmitter transport (GO:0051588) | 3.15143432 |
| 84 | learning (GO:0007612) | 3.14909862 |
| 85 | proline transport (GO:0015824) | 3.14550916 |
| 86 | response to amphetamine (GO:0001975) | 3.14481755 |
| 87 | limb bud formation (GO:0060174) | 3.14159121 |
| 88 | regulation of neurotransmitter levels (GO:0001505) | 3.12519037 |
| 89 | positive regulation of dendritic spine development (GO:0060999) | 3.12095478 |
| 90 | presynaptic membrane assembly (GO:0097105) | 3.11681666 |
| 91 | regulation of glutamate secretion (GO:0014048) | 3.11550882 |
| 92 | visual learning (GO:0008542) | 3.10826292 |
| 93 | regulation of female receptivity (GO:0045924) | 3.10785981 |
| 94 | fear response (GO:0042596) | 3.10525227 |
| 95 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.10419216 |
| 96 | cAMP catabolic process (GO:0006198) | 3.09682865 |
| 97 | dopamine receptor signaling pathway (GO:0007212) | 3.09620431 |
| 98 | C4-dicarboxylate transport (GO:0015740) | 3.09113132 |
| 99 | axonal fasciculation (GO:0007413) | 3.08908058 |
| 100 | dendritic spine organization (GO:0097061) | 3.07537086 |
| 101 | positive regulation of synaptic transmission (GO:0050806) | 3.07168528 |
| 102 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.06531178 |
| 103 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.04993039 |
| 104 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.03988337 |
| 105 | neuromuscular process controlling posture (GO:0050884) | 3.03581714 |
| 106 | neuromuscular process (GO:0050905) | 3.03216579 |
| 107 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.02753066 |
| 108 | synaptic vesicle endocytosis (GO:0048488) | 3.02210623 |
| 109 | axon ensheathment in central nervous system (GO:0032291) | 2.87329534 |
| 110 | central nervous system myelination (GO:0022010) | 2.87329534 |
| 111 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.83968439 |
| 112 | behavioral response to nicotine (GO:0035095) | 2.82959747 |
| 113 | synapse assembly (GO:0007416) | 2.81677639 |
| 114 | neuronal action potential (GO:0019228) | 2.78887582 |
| 115 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.78225003 |
| 116 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.68464820 |
| 117 | protein polyglutamylation (GO:0018095) | 2.60704179 |
| 118 | intraciliary transport (GO:0042073) | 2.59811971 |
| 119 | establishment of mitochondrion localization (GO:0051654) | 2.56442729 |
| 120 | dendrite morphogenesis (GO:0048813) | 2.56190799 |
| 121 | serotonin metabolic process (GO:0042428) | 2.53821212 |
| 122 | righting reflex (GO:0060013) | 2.53769744 |
| 123 | adult walking behavior (GO:0007628) | 2.50237381 |
| 124 | cochlea development (GO:0090102) | 2.49477275 |
| 125 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.48082206 |
| 126 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.48075768 |
| 127 | synapse organization (GO:0050808) | 2.44711175 |
| 128 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.44129064 |
| 129 | regulation of respiratory system process (GO:0044065) | 2.44112567 |
| 130 | atrial cardiac muscle cell action potential (GO:0086014) | 2.43491225 |
| 131 | glycosphingolipid biosynthetic process (GO:0006688) | 2.40977475 |
| 132 | detection of calcium ion (GO:0005513) | 2.40180686 |
| 133 | action potential (GO:0001508) | 2.37529373 |
| 134 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.36647506 |
| 135 | adult behavior (GO:0030534) | 2.36396653 |
| 136 | central nervous system neuron axonogenesis (GO:0021955) | 2.36255636 |
| 137 | neuron fate determination (GO:0048664) | 2.33558623 |
| 138 | short-term memory (GO:0007614) | 2.32376393 |
| 139 | epithelial cilium movement (GO:0003351) | 2.30424583 |
| 140 | cilium organization (GO:0044782) | 2.30081992 |
| 141 | cilium assembly (GO:0042384) | 2.29313527 |
| 142 | positive regulation of synapse assembly (GO:0051965) | 2.28818985 |
| 143 | establishment of nucleus localization (GO:0040023) | 2.28774489 |
| 144 | primary amino compound metabolic process (GO:1901160) | 2.28319548 |
| 145 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.27863788 |
| 146 | innervation (GO:0060384) | 2.27838147 |
| 147 | reflex (GO:0060004) | 2.26066019 |
| 148 | retina layer formation (GO:0010842) | 2.25334958 |
| 149 | protein localization to cilium (GO:0061512) | 2.25165447 |
| 150 | neuromuscular synaptic transmission (GO:0007274) | 2.24434298 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.80335611 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.73296257 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.06548519 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.00467050 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.99408680 |
| 6 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.90470709 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.65009889 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.65009889 |
| 9 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.62681892 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.57846880 |
| 11 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.56232112 |
| 12 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.54438215 |
| 13 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.46432430 |
| 14 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.45919833 |
| 15 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.42348215 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.41742530 |
| 17 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.39305857 |
| 18 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.32919456 |
| 19 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.16226005 |
| 20 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.15537140 |
| 21 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.14160511 |
| 22 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.12792026 |
| 23 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.09915127 |
| 24 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.02119845 |
| 25 | VDR_22108803_ChIP-Seq_LS180_Human | 1.97399718 |
| 26 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.96521922 |
| 27 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.95460585 |
| 28 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.95237862 |
| 29 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.94674320 |
| 30 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.91158225 |
| 31 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.83660332 |
| 32 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.82366603 |
| 33 | * ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.81385495 |
| 34 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.77255144 |
| 35 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.74235405 |
| 36 | EWS_26573619_Chip-Seq_HEK293_Human | 1.74234183 |
| 37 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.70736632 |
| 38 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.69847433 |
| 39 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.66591872 |
| 40 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.64477168 |
| 41 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.57383336 |
| 42 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.55967217 |
| 43 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.50014569 |
| 44 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.46736337 |
| 45 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.43877893 |
| 46 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.43435958 |
| 47 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.42890044 |
| 48 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.42110815 |
| 49 | P300_19829295_ChIP-Seq_ESCs_Human | 1.40614475 |
| 50 | STAT3_23295773_ChIP-Seq_U87_Human | 1.36265159 |
| 51 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.34226828 |
| 52 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.33572689 |
| 53 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.31597055 |
| 54 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.31520287 |
| 55 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.29104417 |
| 56 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.28652117 |
| 57 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.27344533 |
| 58 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.27215409 |
| 59 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.27215409 |
| 60 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.26397874 |
| 61 | * AR_19668381_ChIP-Seq_PC3_Human | 1.26348471 |
| 62 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.25322406 |
| 63 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.25233688 |
| 64 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.24353767 |
| 65 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.22613414 |
| 66 | AR_25329375_ChIP-Seq_VCAP_Human | 1.21878052 |
| 67 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.21802168 |
| 68 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.21341716 |
| 69 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.21326155 |
| 70 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.19960315 |
| 71 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.19687384 |
| 72 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.18689923 |
| 73 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.18416288 |
| 74 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.18383956 |
| 75 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.17995026 |
| 76 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.16985764 |
| 77 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.16395051 |
| 78 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.16259700 |
| 79 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.15581604 |
| 80 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.14834726 |
| 81 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.14599542 |
| 82 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.14590819 |
| 83 | TP53_16413492_ChIP-PET_HCT116_Human | 1.14348295 |
| 84 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.13903533 |
| 85 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13621193 |
| 86 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.13489237 |
| 87 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.13285910 |
| 88 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.13160460 |
| 89 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.12708307 |
| 90 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.12617500 |
| 91 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.12522658 |
| 92 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.11470897 |
| 93 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.10441928 |
| 94 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.09962792 |
| 95 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09852072 |
| 96 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.09780615 |
| 97 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.09403606 |
| 98 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.08851798 |
| 99 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.06143624 |
| 100 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.05207779 |
| 101 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.04988210 |
| 102 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.04900371 |
| 103 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.04794892 |
| 104 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.04010515 |
| 105 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.03538425 |
| 106 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.03298629 |
| 107 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.02986163 |
| 108 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.02812021 |
| 109 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.02554655 |
| 110 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.02517865 |
| 111 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.02380846 |
| 112 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.02303216 |
| 113 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.00153977 |
| 114 | FUS_26573619_Chip-Seq_HEK293_Human | 0.99482585 |
| 115 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.98301100 |
| 116 | KDM2B_26808549_Chip-Seq_K562_Human | 0.97383490 |
| 117 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.96028327 |
| 118 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.95320856 |
| 119 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.95320467 |
| 120 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.95189948 |
| 121 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.93096590 |
| 122 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.92519444 |
| 123 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92255208 |
| 124 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.92255208 |
| 125 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.91893450 |
| 126 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.90726102 |
| 127 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89859865 |
| 128 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.89531640 |
| 129 | RXR_22108803_ChIP-Seq_LS180_Human | 0.89245357 |
| 130 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.89075578 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.45915052 |
| 2 | MP0002822_catalepsy | 4.74982837 |
| 3 | MP0003880_abnormal_central_pattern | 4.69497274 |
| 4 | * MP0003635_abnormal_synaptic_transmissio | 4.14260367 |
| 5 | MP0004270_analgesia | 3.54603455 |
| 6 | * MP0009745_abnormal_behavioral_response | 3.52445040 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.41578504 |
| 8 | MP0002064_seizures | 3.14584558 |
| 9 | MP0009046_muscle_twitch | 3.05685590 |
| 10 | MP0002572_abnormal_emotion/affect_behav | 2.88246688 |
| 11 | MP0001968_abnormal_touch/_nociception | 2.84129456 |
| 12 | MP0001486_abnormal_startle_reflex | 2.80833308 |
| 13 | MP0005423_abnormal_somatic_nervous | 2.71954564 |
| 14 | MP0002272_abnormal_nervous_system | 2.61061360 |
| 15 | MP0002734_abnormal_mechanical_nocicepti | 2.33269256 |
| 16 | MP0001501_abnormal_sleep_pattern | 2.27316142 |
| 17 | MP0005646_abnormal_pituitary_gland | 2.09066493 |
| 18 | MP0002736_abnormal_nociception_after | 2.02046096 |
| 19 | MP0001440_abnormal_grooming_behavior | 1.95346055 |
| 20 | MP0009780_abnormal_chondrocyte_physiolo | 1.93505503 |
| 21 | MP0005386_behavior/neurological_phenoty | 1.87903070 |
| 22 | MP0004924_abnormal_behavior | 1.87903070 |
| 23 | MP0002909_abnormal_adrenal_gland | 1.87267390 |
| 24 | MP0002067_abnormal_sensory_capabilities | 1.85632264 |
| 25 | MP0002557_abnormal_social/conspecific_i | 1.83778809 |
| 26 | MP0008569_lethality_at_weaning | 1.81300725 |
| 27 | MP0008877_abnormal_DNA_methylation | 1.79976975 |
| 28 | MP0003787_abnormal_imprinting | 1.79928264 |
| 29 | MP0001529_abnormal_vocalization | 1.77273411 |
| 30 | MP0002102_abnormal_ear_morphology | 1.76953323 |
| 31 | MP0002733_abnormal_thermal_nociception | 1.76514215 |
| 32 | MP0003136_yellow_coat_color | 1.75617888 |
| 33 | MP0001970_abnormal_pain_threshold | 1.75382268 |
| 34 | MP0002735_abnormal_chemical_nociception | 1.66849482 |
| 35 | MP0001984_abnormal_olfaction | 1.62544870 |
| 36 | MP0000778_abnormal_nervous_system | 1.61694963 |
| 37 | * MP0004811_abnormal_neuron_physiology | 1.61652028 |
| 38 | MP0001188_hyperpigmentation | 1.60253689 |
| 39 | MP0003879_abnormal_hair_cell | 1.58322154 |
| 40 | MP0002184_abnormal_innervation | 1.57999352 |
| 41 | MP0006072_abnormal_retinal_apoptosis | 1.51347058 |
| 42 | MP0004885_abnormal_endolymph | 1.49410119 |
| 43 | MP0003122_maternal_imprinting | 1.46112742 |
| 44 | MP0000955_abnormal_spinal_cord | 1.44921671 |
| 45 | MP0005409_darkened_coat_color | 1.41790023 |
| 46 | MP0002938_white_spotting | 1.41772228 |
| 47 | MP0005253_abnormal_eye_physiology | 1.39025153 |
| 48 | MP0005645_abnormal_hypothalamus_physiol | 1.36357594 |
| 49 | MP0002882_abnormal_neuron_morphology | 1.36250337 |
| 50 | MP0003633_abnormal_nervous_system | 1.36243444 |
| 51 | MP0002066_abnormal_motor_capabilities/c | 1.35802066 |
| 52 | MP0000566_synostosis | 1.33045749 |
| 53 | MP0003329_amyloid_beta_deposits | 1.31646444 |
| 54 | MP0004858_abnormal_nervous_system | 1.30778080 |
| 55 | MP0005187_abnormal_penis_morphology | 1.30329182 |
| 56 | MP0001502_abnormal_circadian_rhythm | 1.26628106 |
| 57 | MP0003890_abnormal_embryonic-extraembry | 1.26543557 |
| 58 | MP0004133_heterotaxia | 1.25357941 |
| 59 | MP0000569_abnormal_digit_pigmentation | 1.24738752 |
| 60 | MP0005248_abnormal_Harderian_gland | 1.18631420 |
| 61 | MP0001905_abnormal_dopamine_level | 1.16669464 |
| 62 | MP0006276_abnormal_autonomic_nervous | 1.16101115 |
| 63 | MP0001177_atelectasis | 1.15928664 |
| 64 | MP0002837_dystrophic_cardiac_calcinosis | 1.15162261 |
| 65 | MP0005551_abnormal_eye_electrophysiolog | 1.12857482 |
| 66 | MP0003631_nervous_system_phenotype | 1.11117570 |
| 67 | MP0002234_abnormal_pharynx_morphology | 1.09444021 |
| 68 | MP0004142_abnormal_muscle_tone | 1.08698320 |
| 69 | MP0002152_abnormal_brain_morphology | 1.07351652 |
| 70 | MP0003119_abnormal_digestive_system | 1.03798706 |
| 71 | MP0008872_abnormal_physiological_respon | 1.03607532 |
| 72 | MP0004145_abnormal_muscle_electrophysio | 1.00960208 |
| 73 | MP0002751_abnormal_autonomic_nervous | 1.00871916 |
| 74 | MP0002653_abnormal_ependyma_morphology | 0.99670821 |
| 75 | MP0004085_abnormal_heartbeat | 0.97436125 |
| 76 | MP0002229_neurodegeneration | 0.96703165 |
| 77 | MP0003195_calcinosis | 0.95950165 |
| 78 | MP0003123_paternal_imprinting | 0.95651613 |
| 79 | MP0003690_abnormal_glial_cell | 0.95122986 |
| 80 | MP0008874_decreased_physiological_sensi | 0.94819704 |
| 81 | MP0002069_abnormal_eating/drinking_beha | 0.93477838 |
| 82 | MP0000631_abnormal_neuroendocrine_gland | 0.93458746 |
| 83 | MP0000751_myopathy | 0.91091849 |
| 84 | MP0003937_abnormal_limbs/digits/tail_de | 0.90954071 |
| 85 | MP0003075_altered_response_to | 0.90744930 |
| 86 | MP0000026_abnormal_inner_ear | 0.89492561 |
| 87 | MP0002233_abnormal_nose_morphology | 0.87206056 |
| 88 | MP0005195_abnormal_posterior_eye | 0.85766610 |
| 89 | MP0000013_abnormal_adipose_tissue | 0.85142881 |
| 90 | MP0008961_abnormal_basal_metabolism | 0.85008709 |
| 91 | MP0008789_abnormal_olfactory_epithelium | 0.84844965 |
| 92 | MP0000647_abnormal_sebaceous_gland | 0.84684937 |
| 93 | MP0000383_abnormal_hair_follicle | 0.84429679 |
| 94 | MP0005167_abnormal_blood-brain_barrier | 0.84115128 |
| 95 | MP0000049_abnormal_middle_ear | 0.82997117 |
| 96 | MP0000427_abnormal_hair_cycle | 0.82728785 |
| 97 | MP0001485_abnormal_pinna_reflex | 0.81172993 |
| 98 | MP0000920_abnormal_myelination | 0.81063077 |
| 99 | MP0003283_abnormal_digestive_organ | 0.81040515 |
| 100 | MP0005394_taste/olfaction_phenotype | 0.80372479 |
| 101 | MP0005499_abnormal_olfactory_system | 0.80372479 |
| 102 | MP0003938_abnormal_ear_development | 0.79686368 |
| 103 | MP0000516_abnormal_urinary_system | 0.79566909 |
| 104 | MP0002090_abnormal_vision | 0.79087001 |
| 105 | MP0001963_abnormal_hearing_physiology | 0.78298774 |
| 106 | MP0004742_abnormal_vestibular_system | 0.77891037 |
| 107 | MP0005535_abnormal_body_temperature | 0.77036881 |
| 108 | MP0003634_abnormal_glial_cell | 0.76590273 |
| 109 | MP0003632_abnormal_nervous_system | 0.72698089 |
| 110 | MP0002752_abnormal_somatic_nervous | 0.70402633 |
| 111 | MP0003137_abnormal_impulse_conducting | 0.69350803 |
| 112 | MP0004215_abnormal_myocardial_fiber | 0.68436097 |
| 113 | MP0003121_genomic_imprinting | 0.67539917 |
| 114 | MP0001664_abnormal_digestion | 0.62644289 |
| 115 | MP0002638_abnormal_pupillary_reflex | 0.58812664 |
| 116 | MP0010386_abnormal_urinary_bladder | 0.58545518 |
| 117 | MP0001943_abnormal_respiration | 0.57287701 |
| 118 | MP0004043_abnormal_pH_regulation | 0.55912571 |
| 119 | MP0001299_abnormal_eye_distance/ | 0.54333334 |
| 120 | MP0004233_abnormal_muscle_weight | 0.54303371 |
| 121 | MP0004484_altered_response_of | 0.52955573 |
| 122 | MP0003861_abnormal_nervous_system | 0.52549310 |
| 123 | MP0006292_abnormal_olfactory_placode | 0.51202596 |
| 124 | MP0010769_abnormal_survival | 0.51129891 |
| 125 | MP0002082_postnatal_lethality | 0.50607402 |
| 126 | MP0010770_preweaning_lethality | 0.50607402 |
| 127 | MP0005171_absent_coat_pigmentation | 0.49770277 |
| 128 | MP0003045_fibrosis | 0.49705915 |
| 129 | MP0010768_mortality/aging | 0.48216874 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.98207823 |
| 2 | Myokymia (HP:0002411) | 7.29407130 |
| 3 | Focal seizures (HP:0007359) | 5.73754570 |
| 4 | Epileptic encephalopathy (HP:0200134) | 4.65664520 |
| 5 | Visual hallucinations (HP:0002367) | 4.48736872 |
| 6 | Febrile seizures (HP:0002373) | 4.33645513 |
| 7 | Action tremor (HP:0002345) | 4.09068601 |
| 8 | Progressive cerebellar ataxia (HP:0002073) | 3.96809097 |
| 9 | Atonic seizures (HP:0010819) | 3.91949253 |
| 10 | Broad-based gait (HP:0002136) | 3.89016092 |
| 11 | Absence seizures (HP:0002121) | 3.76367922 |
| 12 | Generalized tonic-clonic seizures (HP:0002069) | 3.66159054 |
| 13 | Gaze-evoked nystagmus (HP:0000640) | 3.63983865 |
| 14 | Poor eye contact (HP:0000817) | 3.58993748 |
| 15 | Dialeptic seizures (HP:0011146) | 3.49887259 |
| 16 | Dysdiadochokinesis (HP:0002075) | 3.43552209 |
| 17 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.41284280 |
| 18 | Ankle clonus (HP:0011448) | 3.39298563 |
| 19 | Hepatoblastoma (HP:0002884) | 3.30869973 |
| 20 | Depression (HP:0000716) | 3.29231007 |
| 21 | Hyperventilation (HP:0002883) | 3.25822501 |
| 22 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.23394135 |
| 23 | Anxiety (HP:0000739) | 3.20543762 |
| 24 | Impaired social interactions (HP:0000735) | 3.17730152 |
| 25 | Abnormal social behavior (HP:0012433) | 3.17730152 |
| 26 | Truncal ataxia (HP:0002078) | 3.11057145 |
| 27 | Abnormality of the labia minora (HP:0012880) | 3.10180524 |
| 28 | Dysmetria (HP:0001310) | 3.04655964 |
| 29 | Scanning speech (HP:0002168) | 3.03669853 |
| 30 | Postural instability (HP:0002172) | 3.02902415 |
| 31 | Gait imbalance (HP:0002141) | 3.02766693 |
| 32 | Medial flaring of the eyebrow (HP:0010747) | 2.96292530 |
| 33 | Torticollis (HP:0000473) | 2.90995388 |
| 34 | Supranuclear gaze palsy (HP:0000605) | 2.90278359 |
| 35 | Papilledema (HP:0001085) | 2.87378326 |
| 36 | Nephronophthisis (HP:0000090) | 2.84655236 |
| 37 | Impaired smooth pursuit (HP:0007772) | 2.80524193 |
| 38 | Stereotypic behavior (HP:0000733) | 2.77344275 |
| 39 | Pancreatic fibrosis (HP:0100732) | 2.75111981 |
| 40 | Genetic anticipation (HP:0003743) | 2.73738971 |
| 41 | Annular pancreas (HP:0001734) | 2.73292681 |
| 42 | Genital tract atresia (HP:0001827) | 2.72560295 |
| 43 | True hermaphroditism (HP:0010459) | 2.72124345 |
| 44 | Drooling (HP:0002307) | 2.67543315 |
| 45 | Excessive salivation (HP:0003781) | 2.67543315 |
| 46 | Congenital primary aphakia (HP:0007707) | 2.66925806 |
| 47 | Abnormal eating behavior (HP:0100738) | 2.66621864 |
| 48 | Urinary urgency (HP:0000012) | 2.65642460 |
| 49 | Dysmetric saccades (HP:0000641) | 2.65295716 |
| 50 | Vaginal atresia (HP:0000148) | 2.64932984 |
| 51 | Polyphagia (HP:0002591) | 2.62424530 |
| 52 | Focal dystonia (HP:0004373) | 2.60678547 |
| 53 | Amblyopia (HP:0000646) | 2.60270397 |
| 54 | Abnormality of midbrain morphology (HP:0002418) | 2.57969959 |
| 55 | Molar tooth sign on MRI (HP:0002419) | 2.57969959 |
| 56 | Resting tremor (HP:0002322) | 2.56189700 |
| 57 | Intestinal atresia (HP:0011100) | 2.53055725 |
| 58 | Nephrogenic diabetes insipidus (HP:0009806) | 2.52671037 |
| 59 | Mutism (HP:0002300) | 2.49626390 |
| 60 | Spastic gait (HP:0002064) | 2.48163705 |
| 61 | Intention tremor (HP:0002080) | 2.47325480 |
| 62 | Pancreatic cysts (HP:0001737) | 2.47121136 |
| 63 | Hemiparesis (HP:0001269) | 2.46116750 |
| 64 | Impaired vibratory sensation (HP:0002495) | 2.44256951 |
| 65 | Bradykinesia (HP:0002067) | 2.42768275 |
| 66 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.41691697 |
| 67 | Craniofacial dystonia (HP:0012179) | 2.36035446 |
| 68 | Abnormality of the renal medulla (HP:0100957) | 2.35309941 |
| 69 | Hypothermia (HP:0002045) | 2.34392863 |
| 70 | Prolonged QT interval (HP:0001657) | 2.33257505 |
| 71 | Abnormal EKG (HP:0003115) | 2.32895281 |
| 72 | Absent speech (HP:0001344) | 2.32638299 |
| 73 | Pointed chin (HP:0000307) | 2.32372874 |
| 74 | Epileptiform EEG discharges (HP:0011182) | 2.31403855 |
| 75 | Ankyloglossia (HP:0010296) | 2.29312687 |
| 76 | Progressive inability to walk (HP:0002505) | 2.26902941 |
| 77 | Abnormality of the lower motor neuron (HP:0002366) | 2.26780326 |
| 78 | Insidious onset (HP:0003587) | 2.24210315 |
| 79 | Termporal pattern (HP:0011008) | 2.24210315 |
| 80 | Megalencephaly (HP:0001355) | 2.23680715 |
| 81 | Hemiplegia (HP:0002301) | 2.23330737 |
| 82 | Lower limb muscle weakness (HP:0007340) | 2.20892209 |
| 83 | Blue irides (HP:0000635) | 2.18978036 |
| 84 | EEG with generalized epileptiform discharges (HP:0011198) | 2.17051571 |
| 85 | Poor coordination (HP:0002370) | 2.13247478 |
| 86 | Ventricular fibrillation (HP:0001663) | 2.12741628 |
| 87 | Colon cancer (HP:0003003) | 2.10701935 |
| 88 | Status epilepticus (HP:0002133) | 2.10690461 |
| 89 | Protruding tongue (HP:0010808) | 2.08782437 |
| 90 | Lower limb amyotrophy (HP:0007210) | 2.07597916 |
| 91 | Optic nerve hypoplasia (HP:0000609) | 2.07124141 |
| 92 | Hypsarrhythmia (HP:0002521) | 2.05535183 |
| 93 | Fetal akinesia sequence (HP:0001989) | 2.04639584 |
| 94 | Incomplete penetrance (HP:0003829) | 2.03109173 |
| 95 | Neurofibrillary tangles (HP:0002185) | 2.00415616 |
| 96 | Oligodactyly (hands) (HP:0001180) | 1.99916929 |
| 97 | Specific learning disability (HP:0001328) | 1.99778645 |
| 98 | Lissencephaly (HP:0001339) | 1.96612128 |
| 99 | Limb dystonia (HP:0002451) | 1.95867214 |
| 100 | Postaxial hand polydactyly (HP:0001162) | 1.94690043 |
| 101 | Clonus (HP:0002169) | 1.93366472 |
| 102 | Astrocytoma (HP:0009592) | 1.92187220 |
| 103 | Abnormality of the astrocytes (HP:0100707) | 1.92187220 |
| 104 | Inability to walk (HP:0002540) | 1.91794612 |
| 105 | Obstructive sleep apnea (HP:0002870) | 1.89940088 |
| 106 | Gait ataxia (HP:0002066) | 1.89127068 |
| 107 | Abnormality of binocular vision (HP:0011514) | 1.88717823 |
| 108 | Diplopia (HP:0000651) | 1.88717823 |
| 109 | Abnormality of the corticospinal tract (HP:0002492) | 1.87778181 |
| 110 | Renal hypoplasia (HP:0000089) | 1.87393083 |
| 111 | Cerebral inclusion bodies (HP:0100314) | 1.87102263 |
| 112 | Chronic hepatic failure (HP:0100626) | 1.86705053 |
| 113 | Tubulointerstitial nephritis (HP:0001970) | 1.84536480 |
| 114 | Labial hypoplasia (HP:0000066) | 1.84489514 |
| 115 | Bundle branch block (HP:0011710) | 1.84295005 |
| 116 | Aqueductal stenosis (HP:0002410) | 1.83655932 |
| 117 | Abnormality of the renal cortex (HP:0011035) | 1.82853925 |
| 118 | Decreased lacrimation (HP:0000633) | 1.80616892 |
| 119 | Inappropriate behavior (HP:0000719) | 1.80599387 |
| 120 | Generalized myoclonic seizures (HP:0002123) | 1.80012046 |
| 121 | Abnormality of saccadic eye movements (HP:0000570) | 1.77506822 |
| 122 | Anophthalmia (HP:0000528) | 1.77111872 |
| 123 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.75869867 |
| 124 | Lower limb asymmetry (HP:0100559) | 1.75165111 |
| 125 | Narrow forehead (HP:0000341) | 1.74896121 |
| 126 | Type II lissencephaly (HP:0007260) | 1.73809865 |
| 127 | Cystic liver disease (HP:0006706) | 1.73680556 |
| 128 | Pheochromocytoma (HP:0002666) | 1.73656319 |
| 129 | Abnormality of salivation (HP:0100755) | 1.72579595 |
| 130 | Alacrima (HP:0000522) | 1.72379022 |
| 131 | Deeply set eye (HP:0000490) | 1.72274628 |
| 132 | Insomnia (HP:0100785) | 1.72199443 |
| 133 | Cutaneous finger syndactyly (HP:0010554) | 1.72141859 |
| 134 | Obsessive-compulsive behavior (HP:0000722) | 1.69368227 |
| 135 | Bowel incontinence (HP:0002607) | 1.69280293 |
| 136 | Autism (HP:0000717) | 1.68683313 |
| 137 | Neuronal loss in central nervous system (HP:0002529) | 1.68163339 |
| 138 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.67631798 |
| 139 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.67631798 |
| 140 | Gastrointestinal atresia (HP:0002589) | 1.67426868 |
| 141 | Tubular atrophy (HP:0000092) | 1.66688175 |
| 142 | Scrotal hypoplasia (HP:0000046) | 1.66254167 |
| 143 | Methylmalonic acidemia (HP:0002912) | 1.66004815 |
| 144 | Generalized hypopigmentation of hair (HP:0011358) | 1.65979418 |
| 145 | Agitation (HP:0000713) | 1.65771035 |
| 146 | Widely spaced teeth (HP:0000687) | 1.64738862 |
| 147 | Abnormality of the periventricular white matter (HP:0002518) | 1.64574046 |
| 148 | Postaxial foot polydactyly (HP:0001830) | 1.62851796 |
| 149 | Abnormality of the pubic bones (HP:0003172) | 1.62561495 |
| 150 | Hypoplastic female external genitalia (HP:0012815) | 1.62026112 |
| 151 | Broad foot (HP:0001769) | 1.61939498 |
| 152 | Pachygyria (HP:0001302) | 1.61824225 |
| 153 | Abnormal drinking behavior (HP:0030082) | 1.60503473 |
| 154 | Polydipsia (HP:0001959) | 1.60503473 |
| 155 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.59227881 |
| 156 | Glioma (HP:0009733) | 1.59051139 |
| 157 | Esotropia (HP:0000565) | 1.58384142 |
| 158 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.58361866 |
| 159 | Short foot (HP:0001773) | 1.58291126 |
| 160 | Neoplasm of the adrenal cortex (HP:0100641) | 1.57662693 |
| 161 | Neoplasm of the oral cavity (HP:0100649) | 1.56237372 |
| 162 | Sleep apnea (HP:0010535) | 1.56134888 |
| 163 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.55832075 |
| 164 | Volvulus (HP:0002580) | 1.55402933 |
| 165 | Bifid tongue (HP:0010297) | 1.55228083 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 5.95447250 |
| 2 | NTRK3 | 4.52970102 |
| 3 | MAP3K9 | 3.41903707 |
| 4 | FRK | 3.19654879 |
| 5 | MAP3K4 | 2.73288138 |
| 6 | DAPK2 | 2.63741954 |
| 7 | MARK1 | 2.41115699 |
| 8 | MINK1 | 2.34011219 |
| 9 | PRKD3 | 2.29524956 |
| 10 | MAP2K7 | 2.24308067 |
| 11 | RIPK4 | 2.21634137 |
| 12 | TNIK | 2.12927277 |
| 13 | NTRK2 | 2.10851085 |
| 14 | MAP4K2 | 2.02627822 |
| 15 | CAMKK1 | 2.00487439 |
| 16 | KSR2 | 1.98990819 |
| 17 | PAK6 | 1.83446801 |
| 18 | CASK | 1.73062557 |
| 19 | NTRK1 | 1.69406894 |
| 20 | KSR1 | 1.67583649 |
| 21 | BMPR1B | 1.65634187 |
| 22 | DAPK1 | 1.61060227 |
| 23 | MAP2K4 | 1.55322379 |
| 24 | TRIM28 | 1.54984327 |
| 25 | CDK5 | 1.53601003 |
| 26 | PRPF4B | 1.52608566 |
| 27 | FES | 1.50735543 |
| 28 | CAMKK2 | 1.48532293 |
| 29 | STK16 | 1.42626822 |
| 30 | MAPK13 | 1.38805360 |
| 31 | ERBB3 | 1.37290661 |
| 32 | STK39 | 1.35012399 |
| 33 | MAP3K13 | 1.33073054 |
| 34 | SIK2 | 1.32849378 |
| 35 | MAP3K12 | 1.32034335 |
| 36 | CSNK1G1 | 1.30489234 |
| 37 | STK38 | 1.26852336 |
| 38 | MKNK2 | 1.26554380 |
| 39 | CSNK1G3 | 1.25449681 |
| 40 | WNK4 | 1.24410441 |
| 41 | DYRK2 | 1.20940369 |
| 42 | CDK19 | 1.20864435 |
| 43 | MAP3K2 | 1.19815681 |
| 44 | SGK494 | 1.18556252 |
| 45 | SGK223 | 1.18556252 |
| 46 | SGK2 | 1.15610115 |
| 47 | OBSCN | 1.15021301 |
| 48 | TYRO3 | 1.14904050 |
| 49 | ARAF | 1.11588574 |
| 50 | CAMK1 | 1.05558859 |
| 51 | PNCK | 1.05034628 |
| 52 | GRK1 | 1.05005345 |
| 53 | PLK2 | 1.04710507 |
| 54 | PRKCG | 1.04106831 |
| 55 | TAOK1 | 1.03231077 |
| 56 | UHMK1 | 1.01258257 |
| 57 | EPHA3 | 0.98761007 |
| 58 | CSNK1A1L | 0.98048636 |
| 59 | STK38L | 0.96807608 |
| 60 | SGK3 | 0.96799245 |
| 61 | CAMK2A | 0.95974224 |
| 62 | NUAK1 | 0.93833526 |
| 63 | INSRR | 0.91156833 |
| 64 | BMPR2 | 0.90657438 |
| 65 | PINK1 | 0.89300050 |
| 66 | STK11 | 0.88150052 |
| 67 | GRK5 | 0.87956407 |
| 68 | SGK1 | 0.86445483 |
| 69 | RAF1 | 0.83565505 |
| 70 | PRKCH | 0.82990680 |
| 71 | ACVR1B | 0.82170794 |
| 72 | ADRBK2 | 0.81555066 |
| 73 | CAMK2B | 0.81042801 |
| 74 | MARK2 | 0.77795615 |
| 75 | AKT3 | 0.77504525 |
| 76 | PKN1 | 0.77105488 |
| 77 | OXSR1 | 0.76044164 |
| 78 | PTK2B | 0.75550478 |
| 79 | CAMK1G | 0.75367460 |
| 80 | CDK18 | 0.75131178 |
| 81 | MKNK1 | 0.74406247 |
| 82 | CDK15 | 0.71611184 |
| 83 | BRD4 | 0.70798558 |
| 84 | NEK6 | 0.70750242 |
| 85 | RET | 0.70693464 |
| 86 | CDK14 | 0.67216934 |
| 87 | TNK2 | 0.65944948 |
| 88 | PHKG1 | 0.65534188 |
| 89 | PHKG2 | 0.65534188 |
| 90 | PDK1 | 0.64652689 |
| 91 | WNK3 | 0.64061109 |
| 92 | PDPK1 | 0.63722308 |
| 93 | CAMK4 | 0.62374148 |
| 94 | LMTK2 | 0.62177900 |
| 95 | CDK11A | 0.61822848 |
| 96 | WNK1 | 0.61230529 |
| 97 | PLK3 | 0.61189877 |
| 98 | CSNK1E | 0.60723539 |
| 99 | PIK3CA | 0.59434113 |
| 100 | RPS6KA3 | 0.56901093 |
| 101 | MUSK | 0.56712139 |
| 102 | FGFR2 | 0.56631401 |
| 103 | DMPK | 0.54896073 |
| 104 | CSNK1D | 0.54827376 |
| 105 | CSNK1G2 | 0.54776186 |
| 106 | MAP3K1 | 0.53672381 |
| 107 | DYRK1A | 0.53325016 |
| 108 | PRKG1 | 0.52981190 |
| 109 | SIK3 | 0.52943722 |
| 110 | ALK | 0.52334503 |
| 111 | PRKAA1 | 0.51508203 |
| 112 | CDK3 | 0.51494184 |
| 113 | CSNK1A1 | 0.51098011 |
| 114 | PAK3 | 0.50466576 |
| 115 | ZAK | 0.50210666 |
| 116 | MAPK10 | 0.49677626 |
| 117 | MAPK15 | 0.49217978 |
| 118 | CDC42BPA | 0.49113528 |
| 119 | PRKCZ | 0.48693495 |
| 120 | PRKCE | 0.48382684 |
| 121 | CAMK1D | 0.47488181 |
| 122 | FYN | 0.47382821 |
| 123 | * PRKACA | 0.47087376 |
| 124 | PRKACB | 0.45529111 |
| 125 | RIPK1 | 0.42199411 |
| 126 | CAMK2D | 0.41552745 |
| 127 | FGFR1 | 0.41291394 |
| 128 | PRKDC | 0.38722325 |
| 129 | TSSK6 | 0.36929691 |
| 130 | MAP3K7 | 0.36086086 |
| 131 | VRK1 | 0.35957505 |
| 132 | PDK2 | 0.35943358 |
| 133 | MAPKAPK5 | 0.35295708 |
| 134 | ROCK1 | 0.35247520 |
| 135 | ERBB2 | 0.35159506 |
| 136 | PRKCB | 0.35120493 |
| 137 | CAMK2G | 0.35097269 |
| 138 | BRAF | 0.34034972 |
| 139 | MAP2K1 | 0.33973335 |
| 140 | CCNB1 | 0.33842242 |
| 141 | LATS2 | 0.33570967 |
| 142 | BCR | 0.33475577 |
| 143 | FER | 0.32379851 |
| 144 | ADRBK1 | 0.32111485 |
| 145 | PRKD2 | 0.31789127 |
| 146 | EPHB2 | 0.30706322 |
| 147 | FGR | 0.30587254 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.58019152 |
| 2 | Olfactory transduction_Homo sapiens_hsa04740 | 3.11022599 |
| 3 | Circadian entrainment_Homo sapiens_hsa04713 | 2.81804224 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.81627817 |
| 5 | Morphine addiction_Homo sapiens_hsa05032 | 2.73978267 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.72559057 |
| 7 | Long-term potentiation_Homo sapiens_hsa04720 | 2.69681789 |
| 8 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.65676954 |
| 9 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.64132854 |
| 10 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.63593779 |
| 11 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.25623475 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.21669049 |
| 13 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.11437047 |
| 14 | Cocaine addiction_Homo sapiens_hsa05030 | 2.08795700 |
| 15 | Cholinergic synapse_Homo sapiens_hsa04725 | 2.01957558 |
| 16 | Insulin secretion_Homo sapiens_hsa04911 | 2.00820269 |
| 17 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.96736289 |
| 18 | Renin secretion_Homo sapiens_hsa04924 | 1.94439237 |
| 19 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.91556652 |
| 20 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.86984971 |
| 21 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.81763321 |
| 22 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.77634210 |
| 23 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.72769401 |
| 24 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.71871485 |
| 25 | Taste transduction_Homo sapiens_hsa04742 | 1.71478701 |
| 26 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.69026516 |
| 27 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.68051339 |
| 28 | Long-term depression_Homo sapiens_hsa04730 | 1.66212123 |
| 29 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.50620714 |
| 30 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.44250258 |
| 31 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.44183218 |
| 32 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.43145077 |
| 33 | Gap junction_Homo sapiens_hsa04540 | 1.42170672 |
| 34 | Protein export_Homo sapiens_hsa03060 | 1.40369539 |
| 35 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.31727714 |
| 36 | Phototransduction_Homo sapiens_hsa04744 | 1.28200637 |
| 37 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.25011466 |
| 38 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.21371378 |
| 39 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.20951328 |
| 40 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.19543812 |
| 41 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.17471902 |
| 42 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.15139969 |
| 43 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.14944894 |
| 44 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.14069028 |
| 45 | Glioma_Homo sapiens_hsa05214 | 1.11124523 |
| 46 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.10984985 |
| 47 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.09889211 |
| 48 | Axon guidance_Homo sapiens_hsa04360 | 1.08730334 |
| 49 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.07733240 |
| 50 | Melanogenesis_Homo sapiens_hsa04916 | 1.06671973 |
| 51 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.06318673 |
| 52 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.01893182 |
| 53 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.01567761 |
| 54 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.98831004 |
| 55 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.98618123 |
| 56 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.98495822 |
| 57 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.97607087 |
| 58 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.94140928 |
| 59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.93551496 |
| 60 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.93097450 |
| 61 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.90369196 |
| 62 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.89312978 |
| 63 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.87590102 |
| 64 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.87048043 |
| 65 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.84019406 |
| 66 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.83943219 |
| 67 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.83822833 |
| 68 | Histidine metabolism_Homo sapiens_hsa00340 | 0.81344229 |
| 69 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.80820483 |
| 70 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.80505162 |
| 71 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.79495841 |
| 72 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.78310801 |
| 73 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.78090741 |
| 74 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.77523437 |
| 75 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.77022264 |
| 76 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.76882146 |
| 77 | Basal transcription factors_Homo sapiens_hsa03022 | 0.75868141 |
| 78 | Parkinsons disease_Homo sapiens_hsa05012 | 0.74152131 |
| 79 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.73286906 |
| 80 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.72415270 |
| 81 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.72051814 |
| 82 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.72046036 |
| 83 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.72043382 |
| 84 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.71720790 |
| 85 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.70972707 |
| 86 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.70495556 |
| 87 | Alcoholism_Homo sapiens_hsa05034 | 0.69099402 |
| 88 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.68970881 |
| 89 | Circadian rhythm_Homo sapiens_hsa04710 | 0.67321456 |
| 90 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.67196762 |
| 91 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.64615728 |
| 92 | Peroxisome_Homo sapiens_hsa04146 | 0.63808047 |
| 93 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.62544668 |
| 94 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.62115206 |
| 95 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.60971006 |
| 96 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.60468128 |
| 97 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.60257754 |
| 98 | Alzheimers disease_Homo sapiens_hsa05010 | 0.59673923 |
| 99 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.58966504 |
| 100 | ABC transporters_Homo sapiens_hsa02010 | 0.58541493 |
| 101 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.57407295 |
| 102 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.57207606 |
| 103 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.57164412 |
| 104 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.56926495 |
| 105 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.56792309 |
| 106 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.54160495 |
| 107 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.53322357 |
| 108 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.53037095 |
| 109 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.52618799 |
| 110 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.52326503 |
| 111 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.52147849 |
| 112 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.51287822 |
| 113 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.51055160 |
| 114 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.50396760 |
| 115 | Huntingtons disease_Homo sapiens_hsa05016 | 0.50277206 |
| 116 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.50028583 |
| 117 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.49749064 |
| 118 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.48890555 |
| 119 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.48544045 |
| 120 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.47680997 |
| 121 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.47411875 |
| 122 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.46489676 |
| 123 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.46307370 |
| 124 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.45230627 |
| 125 | Endometrial cancer_Homo sapiens_hsa05213 | 0.43985616 |
| 126 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.41317231 |
| 127 | Bile secretion_Homo sapiens_hsa04976 | 0.41094026 |
| 128 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.41016950 |
| 129 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.40462130 |
| 130 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.40388678 |
| 131 | Endocytosis_Homo sapiens_hsa04144 | 0.40113324 |
| 132 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.39900535 |
| 133 | Prion diseases_Homo sapiens_hsa05020 | 0.38938180 |
| 134 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.38506719 |
| 135 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.36799015 |
| 136 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.33966441 |
| 137 | Platelet activation_Homo sapiens_hsa04611 | 0.32518733 |
| 138 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.29398139 |
| 139 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.24232895 |
| 140 | Tight junction_Homo sapiens_hsa04530 | 0.22759805 |
| 141 | Colorectal cancer_Homo sapiens_hsa05210 | 0.20648220 |

